UAS
GSK icon

United Asset Strategies’s GSK GSK Stock Holding History

United Asset Strategies’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-37,418
Closed -$1.72M – 220
2020
Q4 		$1.72M Buy
37,418
+807
+2% +$37.1K 0.27% 76
2020
Q3 		$1.72M Sell
36,611
-2,147
-6% -$108K 0.32% 71
2020
Q2 		$1.98M Sell
38,758
-3,786
-9% -$194K 0.39% 64
2020
Q1 		$2.02M Sell
42,544
-348
-0.8% -$18.6K 0.5% 52
2019
Q4 		$2.52M Sell
42,892
-4,077
-9% -$227K 0.49% 61
2019
Q3 		$2.51M Buy
46,969
+10,599
+29% +$545K 0.55% 58
2019
Q2 		$1.82M Buy
36,370
+3,343
+10% +$168K 0.42% 71
2019
Q1 		$1.73M Sell
33,027
-3,052
-8% -$153K 0.41% 68
2018
Q4 		$1.72M Buy
36,079
+27,601
+326% +$1.36M 0.47% 61
2018
Q3 		$426K Sell
8,478
-80
-0.9% -$4.07K 0.1% 151
2018
Q2 		$431K Hold
8,558
– – 0.11% 151
2018
Q1 		$418K Buy
8,558
+80
+0.9% +$3.73K 0.12% 141
2017
Q4 		$376K Buy
+8,478
New +$392K 0.1% 148
2016
Q2 		– Sell
-8,958
Closed -$454K – 141
2016
Q1 		$454K Buy
8,958
+3
+0% +$149 0.2% 83
2015
Q4 		$452K Buy
+8,955
New +$456K 0.2% 91
2015
Q2 		– Sell
-8,949
Closed -$516K – 132
2015
Q1 		$516K Sell
8,949
-474
-5% -$27.2K 0.24% 80
2014
Q4 		$503K Buy
9,423
+3
+0% +$168 0.22% 84
2014
Q3 		$541K Buy
9,420
+512
+6% +$31.4K 0.24% 82
2014
Q2 		$596K Buy
8,908
+962
+12% +$65.1K 0.29% 76
2014
Q1 		$531K Buy
7,946
+198
+3% +$13.4K 0.3% 68
2013
Q4 		$517K Hold
7,748
– – 0.36% 61
2013
Q3 		$486K Hold
7,748
– – 0.31% 66
2013
Q2 		$484K Buy
+7,748
New +$492K 0.32% 69

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

United Asset Strategies's GSK Position: Q1 2021 in Review

United Asset Strategies sold out of GSK (GSK) in Q1 2021, closing a stake of 37,418 shares — an estimated $1.72M sold.

United Asset Strategies first reported a position in GSK in Q2 2013 and held it in 23 quarters. The position peaked at $2.52M in Q4 2019. 774 funds tracked by Wall St. Rank hold GSK as of Q1 2021.

  • United Asset Strategies reported no remaining GSK position as of Q1 2021 after selling out during the quarter.
  • United Asset Strategies sold 37,418 GSK shares in Q1 2021, an estimated $1.72M.
  • United Asset Strategies first reported a position in GSK in Q2 2013 and held it in 23 quarters.
  • United Asset Strategies's GSK position peaked at $2.52M in Q4 2019.
  • 774 funds tracked by Wall St. Rank held GSK as of Q1 2021.

Based on United Asset Strategies's 13F filing for Q1 2021, filed 27 Apr 2021.